BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 6830930)

  • 21. Brofaromine (CGP 11 305 A) in treatment of depression: biological estimation of plasma concentrations.
    Fritze J; Becker T; Ziegler V; Laux G; Riederer P
    Pharmacopsychiatry; 1990 May; 23(3):131-4. PubMed ID: 2374771
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment response of depressed outpatients unresponsive to both a tricyclic and a monoamine oxidase inhibitor antidepressant.
    McGrath PJ; Stewart JW; Nunes EN; Quitkin FM
    J Clin Psychiatry; 1994 Aug; 55(8):336-9. PubMed ID: 8071301
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Brofaromine in depression: a Canadian multicenter placebo trial and a review of standard drug comparative studies.
    Chouinard G; Saxena BM; Nair NP; Kutcher SP; Bakish D; Bradwejn J; Kennedy SH; Sharma V; Remick RA; Kukha-Mohamad SA
    Clin Neuropharmacol; 1993; 16 Suppl 2():S51-4. PubMed ID: 8313397
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Platelet MAO activity and age at onset of depression in elderly depressed women.
    Alexopoulos GS; Lieberman KW; Young RC; Shamoian CA
    Am J Psychiatry; 1984 Oct; 141(10):1276-8. PubMed ID: 6486267
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The importance of dose in isocarboxazid therapy.
    Davidson J; Turnbull C
    J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):49-52. PubMed ID: 6735995
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low platelet MAO activity in psychiatric patients and plasma factors: no evidence for inhibitory influences on MAO in the circulating platelet population.
    Demisch L; Gebhart P; Kaczmarczyk P; von der Mühlen H; Bochnik HJ
    Biol Psychiatry; 1981 Jan; 16(1):21-33. PubMed ID: 7225472
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Classical monoamine oxidase inhibitor: not registered for, but still a place in the treatment of depression].
    Nolen WA
    Ned Tijdschr Geneeskd; 2003 Oct; 147(40):1940-3. PubMed ID: 14574774
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Platelet MAO activity during treatment with pegylated interferon-alfa in melanoma patients.
    Bannink M; Kruit WH; Van Gool AR; Mulder PG; Sleijfer S; Eggermont AM; Stoter G; Fekkes D
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jan; 29(1):109-14. PubMed ID: 15610952
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Platelet MAO activity in anorexia nervosa patients with and without a major depressive disorder.
    Biederman J; Rivinus TM; Herzog DB; Ferber RA; Harper GP; Orsulak PJ; Harmatz JS; Schildkraut JJ
    Am J Psychiatry; 1984 Oct; 141(10):1244-7. PubMed ID: 6486260
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiovascular effects of phenelzine and amitriptyline in depressed outpatients.
    Robinson DS; Nies A; Corcella J; Cooper TB; Spencer C; Keefover R
    J Clin Psychiatry; 1982 May; 43(5 Pt 2):8-15. PubMed ID: 7042699
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phenelzine v imipramine in atypical depression. A preliminary report.
    Liebowitz MR; Quitkin FM; Stewart JW; McGrath PJ; Harrison W; Rabkin J; Tricamo E; Markowitz JS; Klein DF
    Arch Gen Psychiatry; 1984 Jul; 41(7):669-77. PubMed ID: 6375621
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term sertraline treatment and peripheral biochemical markers in female depressed patients.
    Pivac N; Mück-Seler D; Sagud M; Jakovljević M; Mustapić M; Mihaljević-Peles A
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Aug; 27(5):759-65. PubMed ID: 12921906
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phenelzine treatment of depression with chronic diarrhea.
    Weiss KJ; Schwartz HJ; Berrettini WH
    J Clin Psychiatry; 1982 Jun; 43(6):250-1. PubMed ID: 7085581
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical pharmacology of phenelzine.
    Robinson DS; Nies A; Ravaris CL; Ives JO; Bartlett D
    Arch Gen Psychiatry; 1978 May; 35(5):629-35. PubMed ID: 365127
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of isocarboxazid on platelet MAO activity.
    Davidson J; White H
    Biol Psychiatry; 1983 Sep; 18(9):1075-9. PubMed ID: 6640004
    [No Abstract]   [Full Text] [Related]  

  • 36. Refractory depression treated with high doses of monoamine oxidase inhibitor.
    Guze BH; Baxter LR; Rego J
    J Clin Psychiatry; 1987 Jan; 48(1):31-2. PubMed ID: 3804984
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Platelet monoamine oxidase and sex hormones in a population of depressed patients].
    Poirier MF; Lôo H; Lefur G; Mitrani N
    Encephale; 1985; 11(3):125-9. PubMed ID: 4029076
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sertraline treatment of elderly patients with depression and cognitive impairment.
    Devanand DP; Pelton GH; Marston K; Camacho Y; Roose SP; Stern Y; Sackeim HA
    Int J Geriatr Psychiatry; 2003 Feb; 18(2):123-30. PubMed ID: 12571820
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tyramine sulfate excretion may be a better predictor of antidepressant response than monoamine oxidase activity.
    Stewart JW; Harrison W; Cooper TB; Quitkin FM
    Psychiatry Res; 1988 Aug; 25(2):195-201. PubMed ID: 3051071
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Blood MAO/DBH index and the results of the treatment of endogenous depression].
    Puzyński S; Hauptmann M; Rode A; Kalinowski A; Bidzińska E; Beresewicz M; Bidziński A
    Psychiatr Pol; 1990; 24(3):202-8. PubMed ID: 2084728
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.